Search results
Natixis Advisors L.P. Sells 248 Shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)
ETF DAILY NEWS· 5 hours agoNatixis Advisors L.P. cut its holdings in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) by 0.4% during the fourth quarter, according to the company in its...the ...
Is Invesco Biotechnology & Genome ETF (PBE) a Strong ETF Right Now?
Zacks via Yahoo Finance· 1 day agoCost & Other Expenses Investors...risk, investors should also look at the actual holdings inside the...
Enanta Pharmaceuticals (NASDAQ:ENTA) Given New $22.00 Price Target at JMP Securities
ETF DAILY NEWS· 5 hours agoEnanta Pharmaceuticals (NASDAQ:ENTA – Free Report) had its price objective cut by JMP Securities from $23.00 to $22.00 in a research note released on Tuesday morning, Benzinga reports. They ...
Chardan Capital Cuts Seres Therapeutics (NASDAQ:MCRB) Price Target to $6.00
ETF DAILY NEWS· 8 hours agoSeres Therapeutics (NASDAQ:MCRB – Free Report) had its price objective decreased by Chardan Capital from $8.00 to $6.00 in a report published on Wednesday morning, Benzinga reports. Chardan ...
uniQure (NASDAQ:QURE) Forecasted to Earn Q2 2024 Earnings of ($1.16) Per Share
ETF DAILY NEWS· 7 hours agoWilliam Blair analyst S. Corwin now forecasts that the biotechnology company will earn ($1.16) per share for the quarter, down from their previous estimate of ($1.12). The ...
Sana Biotechnology Inc [SANA] stock for 236,300 USD was sold by Yang Patrick Y – Knox Daily
Knox Daily· 2 days agoFollowing the buying of shares at $5.50 each, the insider now holds 12,446,022 shares. Before that, ARCH Venture Fund X, L.P. had added 1,818,181 shares to its account. In ...
Axxcess Wealth Management LLC Takes $352,000 Position in InvescoBiotechnology & Genome ETF...
ETF DAILY NEWS· 2 days agoAxxcess Wealth Management LLC acquired a new stake in shares of Invesco Biotechnology & Genome ETF (NYSEARCA:PBE – Free Report) during the fourth quarter, HoldingsChannel ...
Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) Receives $50.80 Average Target Price from Brokerages
ETF DAILY NEWS· 5 hours agoArrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR – Get Free Report) has been given an average recommendation of “Moderate Buy” by the eleven brokerages that are presently covering ...
Humacyte Inc (HUMA) Q1 2024 Earnings: Aligns with Analyst Projections Amid Strategic Advances
GuruFocus.com via Yahoo Finance· 16 hours agoThe anticipated PDUFA date set for ...for Humacyte. In conclusion, Humacyte Inc's Q1 2024 performance reflects a strategic alignment of its developmental...
International Assets Investment Management LLC Buys 58,299 Shares of Repligen Co. (NASDAQ:RGEN)
ETF DAILY NEWS· 5 days ago:RGEN – Free Report) by 18,449.1% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 58,615 shares of ...